Enliven Therapeutics, Inc. (ELVN): SC 13D/A filed Aug 28, 2023

Form type

SC 13D/A

Filing date

Aug 28, 2023

Accession number

0001104659-23-095997

Filer

Enliven Therapeutics, Inc. (CIK 1672619)